
About 7Sugar
7Sugar is a Healthcare company based in Bengaluru (India) founded in 2018 by Abhinav Gujjar and Adhi Kesarla. It operates as an online teleconsultation platform for diabetes management is provided. Its chief executive is Adhi Kesarla. Its Indian entity Sensai Healthcare Private Limited reported revenue of βΉ8 Lakh. Its focus areas include HealthTech, Healthcare Booking Platforms, Doctors and Telemedicine. Its competitors include BeatO, DiaHome and mySugarClinic; 1 of its 3 listed competitors has raised funding.
Company details
7Sugar was founded in 2018 in Bengaluru, India, within the healthtech sector. An online platform for teleconsultation focused on diabetes is operated, featuring a mobile app for user-doctor communication and data tracking on food, medication, glucose levels, and lifestyle shared with caregivers. Cloud-based video chat options are supported, along with smart electronic health records, analytics dashboards, and remote monitoring capabilities.
- Headquarters Bengaluru, India
- Founders Abhinav Gujjar, Adhi Kesarla
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website 7sugar.com
- Social LinkedIn
- Legal Name Sensai Healthcare Private Limited
- Date of Incorporation 07 Sep, 2018
- Jurisdiction Bangalore, Karnataka, India
- Annual Revenue₹8 Lakh
FY 2024 · -66% YoY
- Net Loss-₹20.7 Lakh
FY 2024 · -259% margin
- EBITDA-₹19.8 Lakh
FY 2024 · -248% margin
Associated legal entities of 7Sugar
7Sugar operates through Sensai Healthcare Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Sensai Healthcare Private Limited CIN U72900KA2018PTC116130 | Active | 07 Sep 2018 | Bangalore, Karnataka | ₹0.1 Cr | 598 | 2 | View details |
Board of directors of Sensai Healthcare Private Limited (7Sugar)
Sensai Healthcare Private Limited is the primary company behind 7Sugar. The board of Sensai Healthcare Private Limited currently have 2 directors; the longest-serving is Adhinarayan Kesarla, appointed in 2018. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Adhinarayan Kesarla DIN 08150985 | Director | 07 Sep 2018 | 8 yrs 1 mo | Sensai Healthcare Private Limited |
| Abhijit Bhograj DIN 06926918 | Director | 07 Sep 2018 | 8 yrs 1 mo | Sensai Healthcare Private Limited |
People of 7Sugar
2 people are tracked at 7Sugar (2 in leadership).
| Name | Role | Group |
|---|---|---|
Abhinav Gujjar | Co-Founder | Leadership |
Adhi Kesarla | Co-Founder & CEO | Leadership |
Complete people profiles for 7Sugar
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of 7Sugar
Figures of Sensai Healthcare Private Limited, the primary company behind 7Sugar, for FY 2024. Revenue was ₹8 Lakh (-66% year on year). Net loss was -₹20.7 Lakh (-259% margin). EBITDA was -₹19.8 Lakh (-248% margin). Revenue has grown at a compounded annual rate of -31% over three years and +12% over five years.
- ₹8 LakhRevenue · FY 2024 · -66% YoY
- -₹20.7 LakhNet loss · -259% margin
- -₹19.8 LakhEBITDA · -248% margin
- ₹10 LakhPaid-up capital
- 598Employees (provident fund records)
- -31%Revenue CAGR, 3 years
- +12%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Sensai Healthcare Private Limited are on its company page.
Detailed financial statements for 7Sugar
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of 7Sugar
7Sugar has 3 listed competitors in our database, 1 of them funded. They include BeatO, DiaHome and mySugarClinic, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| beatoapp.com | 2015 | Delhi, India | $50.83M | 93 | Smartphone-enabled glucometers and diabetes management apps are provided. | |
| diahome.com | 2021 | Chennai, India | – | 14 | Offers online diabetes consultations, lab tests, medicine delivery, and nutrition advice. | |
| mysugarclinic.com | 2021 | Alappuzha, India | – | – | Provides a platform for diabetes care and management solutions to patients. |
Detailed competitors of 7Sugar
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Clinical IT & Data Platforms
10 companies that operate in the same segment as 7Sugar (Clinical IT & Data Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Provider of fitness memberships encompassing group classes, gyms, and at-home workouts | 2016 | Bengaluru, Karnataka, India | USD 716.99 M | – | 1,832 | |
Employee health benefits are facilitated via a cloud-based platform. | 2007 | Plymouth Meeting, Pennsylvania, United States | USD 228.3 M | – | – | |
Healthcare appointments are booked online via Zocdoc's platform. | 2007 | New York, New York, United States | USD 425.97 M | USD 4.66 M | 1,365 | |
Virtual physical therapy and digital pain care solutions are provided. | 2015 | San Francisco, California, United States | USD 854.44 M | – | 1,746 | |
Tech-enabled mental health solutions for employers are provided. | 2016 | New York, New York, United States | USD 473.73 M | – | 3,902 | |
App-based health insurance is offered to individuals and businesses. | 2016 | Paris, Ile de France, France | USD 863.12 M | – | 1,606 | |
Virtual care programs for managing chronic diseases are provided. | 2011 | San Francisco, California, United States | USD 450.12 M | USD 260.21 M | 992 | |
AI-driven EMR and practice management software is delivered for clinics. | 2010 | Boca Raton, Florida, United States | USD 329.17 M | – | 2,470 | |
Cloud-based administrative tools for healthcare providers are offered. | 1997 | Watertown, United States | USD 40 M | – | – | |
Membership-based primary care platform is offered for employees and consumers. | 2007 | San Francisco, California, United States | USD 402.56 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about 7Sugar
7Sugar was founded in 2018.
7Sugar is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
Adhi Kesarla is the current CEO of 7Sugar. They have also founded this company.
The primary company behind 7Sugar, Sensai Healthcare Private Limited, reported revenue of βΉ8 Lakh for FY 2024, down 66% year on year.
7Sugar was founded in 2018 in Bengaluru, India, within the healthtech sector. An online platform for teleconsultation focused on diabetes is operated, featuring a mobile app for user-doctor communication and data tracking on food, medication, glucose levels, and lifestyle shared with caregivers. Cloud-based video chat options are supported, along with smart electronic health records, analytics dashboards, and remote monitoring capabilities.
7Sugar's top competitors include BeatO, DiaHome and mySugarClinic.
7Sugar operates through Sensai Healthcare Private Limited.
The legal entities of 7Sugar currently have 2 directors, including Adhinarayan Kesarla, Abhijit Bhograj.